Showing 37–48 of 72 results
-
ESOBRICK 40
Rated 5.00 out of 5Background
Gastroesophageal Reflux Disease (GERD) and Functional Dyspepsia are highly prevalent gastrointestinal disorders worldwide. These conditions often coexist, making clinical differentiation difficult.
- The global prevalence of GERD is around 99%, and Functional Dyspepsia affects 20–30% of the general population.
- Proton Pump Inhibitors (PPIs), alone or combined with prokinetic agents, are proven effective in relieving symptoms and improving quality of life in acid-related disorders.
-
ESOBRICK-D
Background
Gastroesophageal Reflux Disease (GERD) and Functional Dyspepsia are highly prevalent gastrointestinal disorders worldwide. These conditions often coexist, making clinical differentiation difficult.
- The global prevalence of GERD is around 99%, and Functional Dyspepsia affects 20–30% of the general population.
- Proton Pump Inhibitors (PPIs), alone or combined with prokinetic agents, are proven effective in relieving symptoms and improving quality of life in acid-related disorders.
-
ESOBRICK-IT
Background
Gastroesophageal Reflux Disease (GERD) and Functional Dyspepsia are highly prevalent gastrointestinal disorders worldwide. These conditions often coexist, making clinical differentiation difficult.
- The global prevalence of GERD is around 99%, and Functional Dyspepsia affects 20–30% of the general population.
- Proton Pump Inhibitors (PPIs), alone or combined with prokinetic agents, are proven effective in relieving symptoms and improving quality of life in acid-related disorders.
-
ESOBRICK-L
Background
Gastroesophageal Reflux Disease (GERD) and Functional Dyspepsia are highly prevalent gastrointestinal disorders worldwide. These conditions often coexist, making clinical differentiation difficult.
- The global prevalence of GERD is around 99%, and Functional Dyspepsia affects 20–30% of the general population.
- Proton Pump Inhibitors (PPIs), alone or combined with prokinetic agents, are proven effective in relieving symptoms and improving quality of life in acid-related disorders.
-
FLAXMOX CV
Background:
The combination Amoxicillin + Clavulanic Acid + Lactic Acid Bacillus is a triple formulation that includes two drug components and one probiotic. Here’s a clear breakdown
a) Amoxicillin
A broad-spectrum penicillin-type (β-lactam) antibiotic.
It works by inhibiting bacterial cell wall synthesis, leading to bacterial death.
Active against many Gram-positive and some Gram-negative bacteria.
b) Clavulanic Acid
A β-lactamase inhibitor (similar role to tazobactam).
It prevents bacterial enzymes (β-lactamases) from destroying amoxicillin, making the antibiotic more effective against resistant strains.
c) Lactic Acid Bacillus
A probiotic (friendly bacteria) added to prevent or reduce antibiotic-associated diarrhea and restore the natural gut flora disturbed by antibiotics.
-
GLOMUNE IV
Background
GLOMUNE IV is a clear, colorless to almost colorless sterile solution of L-Alanyl-L-Glutamine, a dipeptide stable form of glutamine used in parenteral nutrition (TPN).
-
GLOMUNE SACHETS
Background
L‑Glutamine in granule form, which can be used orally as well as through tube feeding. L‑Glutamine, an immuno‑enhancer, serves as an effective fuel for intestinal cells and improves gut function. It is indicated for various critical disorders as under:
-
Glomune ZS
Background
Glomune ZS is a specialized nutritional sachet formulation containing L-Glutamine, Zinc, and Selenium, developed to support immune response, tissue repair, and oxidative stress reduction in patients recovering from cancer, critical illnesses, or severe burns.
It acts as a rapid recovery force, restoring nutritional balance and enhancing healing outcomes in immune-compromised or metabolically stressed individuals.
-
INBERP-40
Background
Pantoprazole is a medication that belongs to a class of drugs called proton pump inhibitors (PPIs). It is used to reduce the amount of acid produced in the stomach.
Common Uses:
Gastroesophageal reflux disease (GERD) – a condition where stomach acid frequently flows back into the esophagus.
Erosive esophagitis – inflammation of the esophagus due to stomach acid.
Stomach ulcers
-
INBERP-80
Background
pantoprazole is a medication that belongs to a class of drugs called proton pump inhibitors (PPIs). It is used to reduce the amount of acid produced in the stomach.
Common Uses:
Gastroesophageal reflux disease (GERD) – a condition where stomach acid frequently flows back into the esophagus.
Erosive esophagitis – inflammation of the esophagus due to stomach acid.
Stomach ulcers
-
INBERP-DSR
Background
1. Pantoprazole
Type: Proton Pump Inhibitor (PPI)
Use: Reduces the amount of acid produced in the stomach.
Common Uses:
Acid reflux (GERD)
Peptic ulcers
Gastritis
Heartburn due to excess stomach acid
How it works: It blocks the proton pumps in the stomach lining that produce acid.
2. Domperidone
Type: Dopamine antagonist (prokinetic and antiemetic)
Use: Helps move food through the stomach more quickly and prevents nausea or vomiting.
Common Uses:
Nausea and vomiting
Bloating, fullness, or indigestion
As an add-on for reflux when stomach emptying is slow
How it works: It increases the movement of the stomach and intestines (motility) and prevents vomiting by acting on the brain’s chemoreceptor zone.
Combination (Pantoprazole + Domperidone)
This combination is often prescribed for:
Acid reflux with bloating or nausea
GERD with delayed gastric emptying
Heartburn not fully relieved by acid reducers alone.

